Avoid one common investing mistake: How I missed 700% gains over 3 years

Don't be so quick to assume the market knows something that you don't.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In 2013 I made my first investment in gold, purchasing shares in Saracen Mineral Holdings Limited (ASX: SAR). I'd done my research, the company was reasonably well funded, had good assets and delivered output at a decent cost.

The price of gold had just plunged to US$1,200 an ounce and the share prices of everyone from Newcrest Mining Limited (ASX: NCM) on down had been wiped out with the gold falls.

Yet Saracen was still profitable, I was expecting the Australian dollar (which bought more than 100 US cents at the time) to fall sharply, and Quantitative Easing (QE) and super-low interest rates were out in force and I expected those to stick around for some time.

I suspected gold might fall a little further, but thought 'fair value' (insofar as gold has a 'fair' value) for the precious metal was around US$1,100 – US$1,200 an ounce. Saracen had a gold hedging program in place for up to US$1,500 an ounce, which was the icing on the cake.

The cherry on top was the fact that – through sheer luck – I bought shares at the very bottom of the market for 14.5 cents apiece. If this is sounding like the perfect investment, it was. Saracen shares now trade for $1.09 each – more than a 700% increase.

Yet I made a profit of just 6% on my investment. How?

I sold my shares just over a month after I bought them. The price of gold had wobbled and, being new to the gold industry, I wasn't confident in my knowledge and instead believed investors and media reports predicting an impending collapse in the value of gold. My mistake was thinking that these investors and media gurus knew something I didn't.

This happens every single day on the ASX

Recently, shares in Bellamy's Australia Ltd (ASX: BAL) and Blackmores Limited (ASX: BKL) crashed 10% in a single day over new import taxes and regulations in China potentially affecting sale of their products. Some in the market opined that this was bad news for the businesses, although Bellamy's released a statement a day later saying that the fears were unfounded.

The trouble was that many investors overreacted, selling their shares after the initial media coverage and without considering the likely impact on the business.

When tins of Bellamy's formula are selling for four times their shelf value on the 'grey market' in China, is an 11% tax likely to have an impact on 'official' (off-the-shelf) sales of Bellamy's products?

Another key fear was apparently that Bellamy's products were no longer eligible to be sold in China. Given that it took nearly 10 years to achieve the China-Australia Free Trade Agreement (ChAFTA), how likely is it that China would suddenly ban all baby food and vitamin imports?

Stranger things have happened and China has a track record of industry protectionism, but on balance it appeared likely that the impact on affected businesses would be minimal. The trouble was that some shareholders believed that analysts and media pundits knew something they didn't, and abandoned ship. The market is reasonably well informed, and if you haven't done your research you are vulnerable to being caught out in this manner.

However, in this (and most) situations, everything investors needed to know was in the public domain. The Motley Fool's head of research, Joe Magyer, on the basis of publicly available information, told members as far back as 29 March 2016:

"Is the demand for Bellamy's infant formula in China likely to be impacted? We don't expect by much, and even less than the 7% hit the shares took today."

Don't make the same expensive mistakes that cost me and Blackmores/Bellamy's shareholders so much money. If you've done your research, it's pretty unlikely that the market knows something you don't.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned, but he does own shares in The Motley Fool's Top Dividend Stock for 2016. The Motley Fool Australia owns shares of Bellamy's Australia. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »